BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28943437)

  • 21. Calcium saccharate/DUSP6 suppresses renal cell carcinoma glycolytic metabolism and boosts sunitinib efficacy via the ERK-AKT pathway.
    Liu H; Wang L; Shi X; Yin L; Zhai W; Gao S; Chen Y; Zhang T
    Biochem Pharmacol; 2024 Jun; 224():116247. PubMed ID: 38697311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
    Pan Q; Liu R; Banu H; Ma L; Li H
    Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
    Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
    Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate.
    Nilsson H; Lindgren D; Mandahl Forsberg A; Mulder H; Axelson H; Johansson ME
    Cell Death Dis; 2015 Jan; 6(1):e1585. PubMed ID: 25569102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cells.
    Fujita M; Tohi M; Sawada K; Yamamoto Y; Nakamura T; Yagami T; Yamamori M; Okamura N
    Oncol Rep; 2012 May; 27(5):1371-6. PubMed ID: 22322451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting glycolysis with 2-deoxy-D-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors.
    Simon AG; Esser LK; Ellinger J; Branchi V; Tolkach Y; Müller S; Ritter M; Kristiansen G; Muders MH; Mayr T; Toma MI
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2255-2265. PubMed ID: 32533404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance.
    Shanmugasundaram K; Nayak BK; Friedrichs WE; Kaushik D; Rodriguez R; Block K
    Nat Commun; 2017 Oct; 8(1):997. PubMed ID: 29051480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choosing the right cell line for renal cell cancer research.
    Brodaczewska KK; Szczylik C; Fiedorowicz M; Porta C; Czarnecka AM
    Mol Cancer; 2016 Dec; 15(1):83. PubMed ID: 27993170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
    Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
    Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
    Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation.
    Beckermann KE; Hongo R; Ye X; Young K; Carbonell K; Healey DCC; Siska PJ; Barone S; Roe CE; Smith CC; Vincent BG; Mason FM; Irish JM; Rathmell WK; Rathmell JC
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft.
    Liu J; Li M; Song B; Jia C; Zhang L; Bai X; Hu W
    Urol Oncol; 2013 Feb; 31(2):264-70. PubMed ID: 21676631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.
    Ferguson RE; Jackson SM; Stanley AJ; Joyce AD; Harnden P; Morrison EE; Patel PM; Phillips RM; Selby PJ; Banks RE
    Int J Cancer; 2005 May; 115(1):155-63. PubMed ID: 15645438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
    Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
    Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carnosine Inhibits the Proliferation of Human Cervical Gland Carcinoma Cells Through Inhibiting Both Mitochondrial Bioenergetics and Glycolysis Pathways and Retarding Cell Cycle Progression.
    Bao Y; Ding S; Cheng J; Liu Y; Wang B; Xu H; Shen Y; Lyu J
    Integr Cancer Ther; 2018 Mar; 17(1):80-91. PubMed ID: 28008780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.